Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Cash (2016 - 2025)

Historic Change in Cash for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $96.7 million.

  • Veracyte's Change in Cash rose 15441.73% to $96.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 4080.46%. This contributed to the annual value of $23.7 million for FY2024, which is 6193.89% down from last year.
  • Veracyte's Change in Cash amounted to $96.7 million in Q3 2025, which was up 15441.73% from $32.8 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Change in Cash registered a high of $96.7 million during Q3 2025, and its lowest value of -$163.5 million during Q3 2021.
  • Over the past 5 years, Veracyte's median Change in Cash value was $9.2 million (recorded in 2021), while the average stood at -$1.7 million.
  • As far as peak fluctuations go, Veracyte's Change in Cash skyrocketed by 34674.39% in 2023, and later tumbled by 64985.84% in 2025.
  • Quarter analysis of 5 years shows Veracyte's Change in Cash stood at $9.2 million in 2021, then tumbled by 273.05% to -$15.9 million in 2022, then skyrocketed by 187.38% to $13.9 million in 2023, then crashed by 346.17% to -$34.1 million in 2024, then skyrocketed by 383.37% to $96.7 million in 2025.
  • Its Change in Cash stands at $96.7 million for Q3 2025, versus $32.8 million for Q2 2025 and -$52.9 million for Q1 2025.